Key facts
- It has raised $5.0M; the latest was Later Stage VC ($5.0M) in Aug 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Vensana Capital
- ·The full record, as it builds
Funding rounds
No funding rounds for Vensana Capital are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vensana Capital
Operator of a venture capital firm intended to invest in development and commercial stage companies across the medtech sector. The company invests in medical devices, diagnostics, data science, drug delivery, digital health, life science tools, and tech-enabled services, enabling companies to grow and seek advancement in the healthcare industry.
- Sector
- Financial Services
- HQ
- Minneapolis, MN, United States
- Founded
- 2019
- Employees
- 20
- Website
- vensanacap.com/
- Ownership
- Privately Held (backing)
Vensana Capital doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vensana Capital shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vensana Capital in its N-PORT filings yet. We sweep new filings monthly.